As the global economy recovers in 2021 and the supply of the industrial chain improves, the ADHD Medication market will undergo major changes. According to the latest research, the market size of the ADHD Medication industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global ADHD Medication industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global ADHD Medication market during the next few years. The global ADHD Medication market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of ADHD Medication market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Stimulant
Non-stimulant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Attention Deficit
Hyperactivity/impulse Control Disorder
Hybrid
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ADHD Medication Market Size 2017-2028
2.1.2 ADHD Medication Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 ADHD Medication Segment by Type
2.2.1 Stimulant
2.2.2 Non-stimulant
2.3 ADHD Medication Market Size by Type
2.3.1 ADHD Medication Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global ADHD Medication Market Size Market Share by Type (2017-2022)
2.4 ADHD Medication Segment by Application
2.4.1 Attention Deficit
2.4.2 Hyperactivity/impulse Control Disorder
2.4.3 Hybrid
2.5 ADHD Medication Market Size by Application
2.5.1 ADHD Medication Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global ADHD Medication Market Size Market Share by Application (2017-2022)
3 ADHD Medication Market Size by Player
3.1 ADHD Medication Market Size Market Share by Players
3.1.1 Global ADHD Medication Revenue by Players (2020-2022)
3.1.2 Global ADHD Medication Revenue Market Share by Players (2020-2022)
3.2 Global ADHD Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADHD Medication by Regions
4.1 ADHD Medication Market Size by Regions (2017-2022)
4.2 Americas ADHD Medication Market Size Growth (2017-2022)
4.3 APAC ADHD Medication Market Size Growth (2017-2022)
4.4 Europe ADHD Medication Market Size Growth (2017-2022)
4.5 Middle East & Africa ADHD Medication Market Size Growth (2017-2022)
5 Americas
5.1 Americas ADHD Medication Market Size by Country (2017-2022)
5.2 Americas ADHD Medication Market Size by Type (2017-2022)
5.3 Americas ADHD Medication Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ADHD Medication Market Size by Region (2017-2022)
6.2 APAC ADHD Medication Market Size by Type (2017-2022)
6.3 APAC ADHD Medication Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe ADHD Medication by Country (2017-2022)
7.2 Europe ADHD Medication Market Size by Type (2017-2022)
7.3 Europe ADHD Medication Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ADHD Medication by Region (2017-2022)
8.2 Middle East & Africa ADHD Medication Market Size by Type (2017-2022)
8.3 Middle East & Africa ADHD Medication Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global ADHD Medication Market Forecast
10.1 Global ADHD Medication Forecast by Regions (2023-2028)
10.1.1 Global ADHD Medication Forecast by Regions (2023-2028)
10.1.2 Americas ADHD Medication Forecast
10.1.3 APAC ADHD Medication Forecast
10.1.4 Europe ADHD Medication Forecast
10.1.5 Middle East & Africa ADHD Medication Forecast
10.2 Americas ADHD Medication Forecast by Country (2023-2028)
10.2.1 United States ADHD Medication Market Forecast
10.2.2 Canada ADHD Medication Market Forecast
10.2.3 Mexico ADHD Medication Market Forecast
10.2.4 Brazil ADHD Medication Market Forecast
10.3 APAC ADHD Medication Forecast by Region (2023-2028)
10.3.1 China ADHD Medication Market Forecast
10.3.2 Japan ADHD Medication Market Forecast
10.3.3 Korea ADHD Medication Market Forecast
10.3.4 Southeast Asia ADHD Medication Market Forecast
10.3.5 India ADHD Medication Market Forecast
10.3.6 Australia ADHD Medication Market Forecast
10.4 Europe ADHD Medication Forecast by Country (2023-2028)
10.4.1 Germany ADHD Medication Market Forecast
10.4.2 France ADHD Medication Market Forecast
10.4.3 UK ADHD Medication Market Forecast
10.4.4 Italy ADHD Medication Market Forecast
10.4.5 Russia ADHD Medication Market Forecast
10.5 Middle East & Africa ADHD Medication Forecast by Region (2023-2028)
10.5.1 Egypt ADHD Medication Market Forecast
10.5.2 South Africa ADHD Medication Market Forecast
10.5.3 Israel ADHD Medication Market Forecast
10.5.4 Turkey ADHD Medication Market Forecast
10.5.5 GCC Countries ADHD Medication Market Forecast
10.6 Global ADHD Medication Forecast by Type (2023-2028)
10.7 Global ADHD Medication Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda ADHD Medication Product Offered
11.1.3 Takeda ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson ADHD Medication Product Offered
11.2.3 Johnson & Johnson ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis ADHD Medication Product Offered
11.3.3 Novartis ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly ADHD Medication Product Offered
11.4.3 Eli Lilly ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Tris Pharma, Inc
11.5.1 Tris Pharma, Inc Company Information
11.5.2 Tris Pharma, Inc ADHD Medication Product Offered
11.5.3 Tris Pharma, Inc ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Tris Pharma, Inc Main Business Overview
11.5.5 Tris Pharma, Inc Latest Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Information
11.6.2 Neos Therapeutics ADHD Medication Product Offered
11.6.3 Neos Therapeutics ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Neos Therapeutics Main Business Overview
11.6.5 Neos Therapeutics Latest Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Information
11.7.2 Mallinckrodt ADHD Medication Product Offered
11.7.3 Mallinckrodt ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mallinckrodt Main Business Overview
11.7.5 Mallinckrodt Latest Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Information
11.8.2 Amneal Pharmaceuticals ADHD Medication Product Offered
11.8.3 Amneal Pharmaceuticals ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Amneal Pharmaceuticals Main Business Overview
11.8.5 Amneal Pharmaceuticals Latest Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Information
11.9.2 Noven Pharmaceuticals ADHD Medication Product Offered
11.9.3 Noven Pharmaceuticals ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Noven Pharmaceuticals Main Business Overview
11.9.5 Noven Pharmaceuticals Latest Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Information
11.10.2 Purdue Parma ADHD Medication Product Offered
11.10.3 Purdue Parma ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Purdue Parma Main Business Overview
11.10.5 Purdue Parma Latest Developments
11.11 Zhengda Fenghai
11.11.1 Zhengda Fenghai Company Information
11.11.2 Zhengda Fenghai ADHD Medication Product Offered
11.11.3 Zhengda Fenghai ADHD Medication Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Zhengda Fenghai Main Business Overview
11.11.5 Zhengda Fenghai Latest Developments
12 Research Findings and Conclusion
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai
*If Applicable.